Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 191

1.

Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013.

Omore R, Khagayi S, Ogwel B, Onkoba R, Ochieng JB, Juma J, Munga S, Tabu C, Kibet S, Nuorti JP, Odhiambo F, Mwenda JM, Breiman RF, Parashar UD, Tate JE.

BMC Infect Dis. 2019 Jan 11;19(1):47. doi: 10.1186/s12879-018-3615-6.

2.

Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.

Mujuru HA, Burnett E, Nathoo KJ, Ticklay I, Gonah NA, Mukaratirwa A, Berejena C, Manangazira P, Rupfutse M, Weldegebriel GG, Mwenda JM, Yen C, Parashar UD, Tate JE.

Clin Infect Dis. 2018 Dec 23. doi: 10.1093/cid/ciy1096. [Epub ahead of print]

PMID:
30590488
3.

Approaches to Monitoring Intussusception Following Rotavirus Vaccination.

Tate JE, Parashar UD.

Expert Opin Drug Saf. 2018 Dec 20. doi: 10.1080/14740338.2019.1561857. [Epub ahead of print]

PMID:
30570424
4.

Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2 years of age in four Asian countries.

Burnett E, Van Trang N, Rayamajhi A, Yousafzai MT, Satter SM, Anh DD, Thapa A, Qazi SH, Heffelfinger JD, Hung PH, Rayamajhi AK, Saddal N, Flora MS, Canh TM, Ali SA, Gurley ES, Tate JE, Yen C, Parashar UD.

Vaccine. 2018 Nov 29;36(50):7593-7598. doi: 10.1016/j.vaccine.2018.11.002. Epub 2018 Nov 7.

PMID:
30414781
5.

Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis.

Chavers T, De Oliveira LH, Parashar UD, Tate JE.

Expert Rev Vaccines. 2018 Nov;17(11):1037-1051. doi: 10.1080/14760584.2018.1541409. Epub 2018 Nov 7.

PMID:
30365904
6.

Intussusception after Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Parashar UD.

N Engl J Med. 2018 Sep 27;379(13):1288-1289. doi: 10.1056/NEJMc1807645. No abstract available.

PMID:
30257154
7.

Effectiveness of monovalent rotavirus vaccine in the Philippines.

Lopez AL, Daag JV, Esparagoza J, Bonifacio J, Fox K, Nyambat B, Parashar UD, Ducusin MJ, Tate JE.

Sci Rep. 2018 Sep 24;8(1):14291. doi: 10.1038/s41598-018-32595-9.

8.

Diarrhea-Associated Mortality in Children Less Than 5 Years of Age in the United States, 2005-2016.

Aliabadi N, Pham H, Curns AT, Rha B, Tate JE, Parashar UD.

Pediatr Infect Dis J. 2018 Sep 19. doi: 10.1097/INF.0000000000002199. [Epub ahead of print]

PMID:
30239475
9.

Using surveillance and economic data to make informed decisions about rotavirus vaccine introduction.

Cohen AL, Aliabadi N, Serhan F, Tate JE, Zuber P, Parashar UD.

Vaccine. 2018 Dec 14;36(51):7755-7758. doi: 10.1016/j.vaccine.2018.05.052. Epub 2018 Aug 18.

PMID:
30131194
10.

Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study.

Bar-Zeev N, King C, Phiri T, Beard J, Mvula H, Crampin AC, Heinsbroek E, Lewycka S, Tate JE, Parashar UD, Costello A, Mwansambo C, Heyderman RS, French N, Cunliffe NA; VacSurv Consortium.

Lancet Glob Health. 2018 Sep;6(9):e1036-e1044. doi: 10.1016/S2214-109X(18)30314-0. Erratum in: Lancet Glob Health. 2018 Dec;6(12):e1286.

11.

Safety monitoring of ROTAVAC vaccine and etiological investigation of intussusception in India: study protocol.

Reddy S, Nair NP, Giri S, Mohan VR, Tate JE, Parashar UD, Gupte MD, Arora R, Kang G; Indian Intussusception Surveillance Network.

BMC Public Health. 2018 Jul 20;18(1):898. doi: 10.1186/s12889-018-5809-7.

12.

Longer-term direct and indirect effects of infant rotavirus vaccination across all ages in the US; 2000 - 2013: analysis of a large hospital discharge dataset.

Baker JM, Tate JE, Steiner CA, Haber MJ, Parashar UD, Lopman BA.

Clin Infect Dis. 2018 Jul 18. doi: 10.1093/cid/ciy580. [Epub ahead of print]

PMID:
30020438
13.

A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness.

Haber M, Lopman BA, Tate JE, Shi M, Parashar UD.

Vaccine. 2018 Aug 9;36(33):5071-5076. doi: 10.1016/j.vaccine.2018.06.072. Epub 2018 Jul 3.

PMID:
29980389
14.

Impact of rotavirus vaccines in Sub-Saharan African countries.

Mwenda JM, Parashar UD, Cohen AL, Tate JE.

Vaccine. 2018 Nov 12;36(47):7119-7123. doi: 10.1016/j.vaccine.2018.06.026. Epub 2018 Jun 18.

PMID:
29914848
15.

A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact.

Pindyck T, Tate JE, Parashar UD.

Expert Rev Vaccines. 2018 Jul;17(7):593-606. doi: 10.1080/14760584.2018.1489724. Epub 2018 Jul 2. Review.

PMID:
29909693
16.

Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015.

Simwaka JC, Mpabalwani EM, Seheri M, Peenze I, Monze M, Matapo B, Parashar UD, Mufunda J, Mphahlele JM, Tate JE, Mwenda JM.

Vaccine. 2018 Nov 12;36(47):7243-7247. doi: 10.1016/j.vaccine.2018.03.035. Epub 2018 Jun 12.

PMID:
29907481
17.

Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction.

Bennett A, Pollock L, Jere KC, Pitzer VE, Parashar U, Tate JE, Heyderman RS, Mwansambo C, French N, Nakagomi O, Iturriza-Gomara M, Everett D, Cunliffe NA, Bar-Zeev N; VacSurv Consortium.

Vaccine. 2018 Nov 12;36(47):7142-7148. doi: 10.1016/j.vaccine.2018.04.030. Epub 2018 Jun 7.

18.

Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.

Mpabalwani EM, Simwaka JC, Mwenda JM, Matapo B, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7165-7169. doi: 10.1016/j.vaccine.2018.02.077. Epub 2018 May 21.

PMID:
29793891
19.

Rotavirus Vaccination Is Associated With Reduced Seizure Hospitalization Risk Among Commercially Insured US Children.

Burke RM, Tate JE, Dahl RM, Aliabadi N, Parashar UD.

Clin Infect Dis. 2018 Oct 30;67(10):1614-1616. doi: 10.1093/cid/ciy424.

PMID:
29788180
20.

Global rotavirus vaccine introductions and coverage: 2006 - 2016.

Abou-Nader AJ, Sauer MA, Steele AD, Tate JE, Atherly D, Parashar UD, Santosham M, Nelson EAS.

Hum Vaccin Immunother. 2018;14(9):2281-2296. doi: 10.1080/21645515.2018.1470725. Epub 2018 Jun 18.

21.

Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda.

Sibomana H, Rugambwa C, Mwenda JM, Sayinzoga F, Iraguha G, Uwimana J, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7135-7141. doi: 10.1016/j.vaccine.2018.01.072. Epub 2018 May 10.

PMID:
29754701
22.

Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5 years of age, Ghana, 2009-2016.

Enweronu-Laryea CC, Armah G, Sagoe KW, Ansong D, Addo-Yobo E, Diamenu SK, Mwenda JM, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7131-7134. doi: 10.1016/j.vaccine.2018.02.058. Epub 2018 May 8.

PMID:
29752020
23.

Impact of rotavirus vaccine on diarrheal hospitalization and outpatient consultations in the Philippines: First evidence from a middle-income Asian country.

Lopez AL, Raguindin PF, Esparagoza J, Fox K, Batmunkh N, Bonifacio J, Parashar UD, Tate JE, Ducusin MJ.

Vaccine. 2018 May 31;36(23):3308-3314. doi: 10.1016/j.vaccine.2018.04.058. Epub 2018 May 3.

24.

Three Rotavirus Outbreaks in the Postvaccine Era - California, 2017.

Burke RM, Tate JE, Barin N, Bock C, Bowen MD, Chang D, Gautam R, Han G, Holguin J, Huynh T, Pan CY, Quenelle R, Sallenave C, Torres C, Wadford D, Parashar U.

MMWR Morb Mortal Wkly Rep. 2018 Apr 27;67(16):470-472. doi: 10.15585/mmwr.mm6716a3.

25.

Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, Mujuru H, Mpabalwani E, Ngwira B, Cortese MM, Mihigo R, Glover-Addy H, Mbaga M, Osawa F, Tadesse A, Mbuwayesango B, Simwaka J, Cunliffe N, Lopman BA, Weldegebriel G, Ansong D, Msuya D, Ogwel B, Karengera T, Manangazira P, Bvulani B, Yen C, Zawaira FR, Narh CT, Mboma L, Saula P, Teshager F, Getachew H, Moeti RM, Eweronu-Laryea C, Parashar UD; African Intussusception Surveillance Network.

N Engl J Med. 2018 Apr 19;378(16):1521-1528. doi: 10.1056/NEJMoa1713909.

26.

Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction.

Mukaratirwa A, Berejena C, Nziramasanga P, Ticklay I, Gonah A, Nathoo K, Manangazira P, Mangwanya D, Marembo J, Mwenda JM, Weldegebriel G, Seheri M, Tate JE, Yen C, Parashar U, Mujuru H.

Vaccine. 2018 Nov 12;36(47):7248-7255. doi: 10.1016/j.vaccine.2018.03.069. Epub 2018 Apr 5.

PMID:
29628149
27.

Recurrent intussusception among infants less than 2 years of age in Vietnam.

Trang NV, Burnett E, Ly LH, Anh NP, Hung PH, Linh HM, Trang NCT, Canh TM, Minh VT, Tate JE, Yen C, Anh DD, Parashar UD.

Vaccine. 2018 Dec 14;36(51):7901-7905. doi: 10.1016/j.vaccine.2018.02.056. Epub 2018 Feb 23.

PMID:
29478753
28.

Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia.

Burnett E, Tate JE, Kirkwood CD, Nelson EAS, Santosham M, Steele AD, Parashar UD.

Expert Rev Vaccines. 2018 May;17(5):453-460. doi: 10.1080/14760584.2018.1443008. Epub 2018 Feb 26.

PMID:
29463143
29.

Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013.

Liu N, Yen C, Huang T, Cui P, Tate JE, Jiang B, Parashar UD, Duan ZJ.

Vaccine. 2018 Dec 14;36(51):7862-7867. doi: 10.1016/j.vaccine.2018.02.032. Epub 2018 Feb 10.

PMID:
29439864
30.

Effect of Rotavirus Vaccination on Acute Diarrheal Hospitalizations Among Low and Very Low Birth Weight US Infants, 2001-2015.

Dahl RM, Curns AT, Tate JE, Parashar UD.

Pediatr Infect Dis J. 2018 Aug;37(8):817-822. doi: 10.1097/INF.0000000000001930.

PMID:
29406466
31.

Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.

Tsolenyanu E, Djadou KE, Fiawoo M, Akolly DAE, Mwenda JM, Leshem E, Tate JE, Aliabadi N, Koudema W, Guedenon KM, Godonou M, Dagnra A, Gbadoe AD, Boko A, Landoh D, Atakouma Y, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7185-7191. doi: 10.1016/j.vaccine.2018.01.058. Epub 2018 Feb 1.

PMID:
29397224
32.

Effect of Age at Vaccination on Rotavirus Vaccine Effectiveness in Bolivian Infants.

Burke RM, Tate JE, Pringle KD, Patel M, De Oliveira LH, Parashar UD.

Pediatr Infect Dis J. 2018 Aug;37(8):e216-e221. doi: 10.1097/INF.0000000000001907.

PMID:
29341984
33.

Trends in Rate of Seizure-Associated Hospitalizations Among Children <5 Years Old Before and After Rotavirus Vaccine Introduction in the United Sates, 2000-2013.

Pringle KD, Burke RM, Steiner CA, Parashar UD, Tate JE.

J Infect Dis. 2018 Jan 30;217(4):581-588. doi: 10.1093/infdis/jix589.

PMID:
29325147
34.

Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.

Bonkoungou IJO, Aliabadi N, Leshem E, Kam M, Nezien D, Drabo MK, Nikiema M, Ouedraogo B, Medah I, Konaté S, Ouédraogo-Traoré R, Sangaré L, Kam L, Yé D, Ouattara M, Biey JN, Mwenda JM, Tate JE, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7170-7178. doi: 10.1016/j.vaccine.2017.12.056. Epub 2017 Dec 28.

PMID:
29290478
35.

Evaluation of the Influence of Gastrointestinal Coinfections on Rotavirus Vaccine Effectiveness in Botswana.

Mokomane M, Tate JE, Steenhoff AP, Esona MD, Bowen MD, Lechiile K, Pernica JM, Kasvosve I, Parashar UD, Goldfarb DM.

Pediatr Infect Dis J. 2018 Mar;37(3):e58-e62. doi: 10.1097/INF.0000000000001828.

PMID:
29189612
36.

Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal.

Rayamajhi A, Thapa A, Kumar M, Yen C, Tate JE, Parashar UD, Rayamajhi AK.

Vaccine. 2018 Dec 14;36(51):7836-7840. doi: 10.1016/j.vaccine.2017.11.022. Epub 2017 Nov 21.

PMID:
29169894
37.

Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar.

Diop A, Thiongane A, Mwenda JM, Aliabadi N, Sonko MA, Diallo A, Ndoye B, Faye PM, Ba ID, Parashar UD, Tate JE, Ndiaye O, Cissé MF, Ba M.

Vaccine. 2018 Nov 12;36(47):7192-7197. doi: 10.1016/j.vaccine.2017.10.061. Epub 2017 Nov 20.

PMID:
29162319
38.

Emergence of Double- and Triple-Gene Reassortant G1P[8] Rotaviruses Possessing a DS-1-Like Backbone after Rotavirus Vaccine Introduction in Malawi.

Jere KC, Chaguza C, Bar-Zeev N, Lowe J, Peno C, Kumwenda B, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Cunliffe NA, Iturriza-Gomara M.

J Virol. 2018 Jan 17;92(3). pii: e01246-17. doi: 10.1128/JVI.01246-17. Print 2018 Feb 1.

39.

Early impact of rotavirus vaccination in children less than five years of age in Mozambique.

de Deus N, Chilaúle JJ, Cassocera M, Bambo M, Langa JS, Sitoe E, Chissaque A, Anapakala E, Sambo J, Guimarães EL, Bero DM, João ED, Cossa-Moiane I, Mwenda JM, Weldegebriel GG, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7205-7209. doi: 10.1016/j.vaccine.2017.10.060. Epub 2017 Nov 8.

PMID:
29128381
40.

Rotavirus infection.

Crawford SE, Ramani S, Tate JE, Parashar UD, Svensson L, Hagbom M, Franco MA, Greenberg HB, O'Ryan M, Kang G, Desselberger U, Estes MK.

Nat Rev Dis Primers. 2017 Nov 9;3:17083. doi: 10.1038/nrdp.2017.83. Review.

41.

Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.

Weldegebriel G, Mwenda JM, Chakauya J, Daniel F, Masresha B, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7124-7130. doi: 10.1016/j.vaccine.2017.10.050. Epub 2017 Nov 6.

PMID:
29102168
42.

Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.

Mwenda JM, Burke RM, Shaba K, Mihigo R, Tevi-Benissan MC, Mumba M, Biey JN, Cheikh D, Poy MSc A, Zawaira FR, Aliabadi N, Tate JE, Hyde T, Cohen AL, Parashar UD.

MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1192-1196. doi: 10.15585/mmwr.mm6643a7.

43.

National Estimates of Reductions in Acute Gastroenteritis-Related Hospitalizations and Associated Costs in US Children After Implementation of Rotavirus Vaccines.

Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):257-260. doi: 10.1093/jpids/pix057.

PMID:
28992205
44.

The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.

Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, Babji S, Sarkar R, Kaliappan PS, Venugopal S, Praharaj I, Raman U, Paranjpe M, Grassly NC, Parker EPK, Parashar UD, Tate JE, Fleming JA, Steele AD, Muliyil J, Abraham AM, Kang G.

Vaccine. 2018 Jan 4;36(2):273-279. doi: 10.1016/j.vaccine.2017.07.116. Epub 2017 Sep 2.

45.

Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.

Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD.

Expert Rev Vaccines. 2017 Oct;16(10):987-995. doi: 10.1080/14760584.2017.1371595. Epub 2017 Sep 4. Review.

PMID:
28832219
46.

Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland.

Maphalala G, Phungwayo N, Masona G, Lukhele N, Tsegaye G, Dube N, Sindisiwe D, Khumalo L, Daniel F, Katsande R, Tate JE, Mwenda JM, Weldegebriel G.

Vaccine. 2018 Nov 12;36(47):7210-7214. doi: 10.1016/j.vaccine.2017.07.072. Epub 2017 Aug 1.

PMID:
28778615
47.

Intussusception-related Hospitalizations Among Infants Before and After Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.

Yen C, Shih SM, Tate JE, Wu FT, Huang YC, Parashar UD, Hsiung CA.

Pediatr Infect Dis J. 2017 Oct;36(10):e252-e257. doi: 10.1097/INF.0000000000001644.

PMID:
28640005
48.

Reduction in Diarrhea- and Rotavirus-related Healthcare Visits Among Children <5 Years of Age After National Rotavirus Vaccine Introduction in Zimbabwe.

Mujuru HA, Yen C, Nathoo KJ, Gonah NA, Ticklay I, Mukaratirwa A, Berejena C, Tapfumanei O, Chindedza K, Rupfutse M, Weldegebriel G, Mwenda JM, Burnett E, Tate JE, Parashar UD, Manangazira P.

Pediatr Infect Dis J. 2017 Oct;36(10):995-999. doi: 10.1097/INF.0000000000001648.

49.

Impact and cost-effectiveness of rotavirus vaccination in Bangladesh.

Pecenka C, Parashar U, Tate JE, Khan JAM, Groman D, Chacko S, Shamsuzzaman M, Clark A, Atherly D.

Vaccine. 2017 Jul 13;35(32):3982-3987. doi: 10.1016/j.vaccine.2017.05.087. Epub 2017 Jun 13.

50.

Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006-2016.

Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD.

Clin Infect Dis. 2017 Sep 1;65(5):840-850. doi: 10.1093/cid/cix369. Review.

PMID:
28444323

Supplemental Content

Support Center